000300095 001__ 300095
000300095 005__ 20250325112353.0
000300095 0247_ $$2doi$$a10.1016/j.lungcan.2025.108500
000300095 0247_ $$2pmid$$apmid:40117846
000300095 0247_ $$2ISSN$$a0169-5002
000300095 0247_ $$2ISSN$$a1872-8332
000300095 037__ $$aDKFZ-2025-00595
000300095 041__ $$aEnglish
000300095 082__ $$a610
000300095 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000300095 245__ $$aLung cancer risk between maternal and paternal half-siblings points to main environmental causation and targets for prevention.
000300095 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2025
000300095 3367_ $$2DRIVER$$aarticle
000300095 3367_ $$2DataCite$$aOutput Types/Journal article
000300095 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1742820775_15477
000300095 3367_ $$2BibTeX$$aARTICLE
000300095 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300095 3367_ $$00$$2EndNote$$aJournal Article
000300095 520__ $$aFamilial risk of lung cancer (LC) is at the level of many common cancers (ca 2.0) but as cigarette smoking is the main cause of LC, it has remained undefined to what extent smoking contributes to the familial risk. We take advantage of the natural experiment of divorce. In Sweden, it has been customary that children stay with their mother after divorce. We thus hypothesize that only maternal half-siblings share the childhood environment to the same extent than full siblings.We used Swedish nation-wide data on family structures and cancers up to year 2021 to determined LC risk (standardized incidence ratio, SIR with 95% confidence intervals) in maternal and paternal half-siblings and in full siblings.Familial risk for LC in maternal half-siblings was 2.21 (1.76-2.77) which was not different from that of full siblings 2.23 (2.22-2.44). For paternal half-siblings the risk was 1.56 (1.21-2.01). For adenocarcinoma the risks were for full siblings 2.36 (2.23-2.51), for maternal half-siblings 2.55 (1.93-3.35) and for paternal half-siblings 1.33 (0.94-1.87).The results showed that familial risk for LC was equal in full siblings and in maternal half-siblings; the risks for paternal half-siblings were lower and for adenocarcinoma significantly lower than those for full siblings. The results suggest that smoking is a major contributor to familial risk of LC in this setting. Smoking starts at an early age and anti-smoking campaigns should target childhood environment for prevention of smoking initiation.
000300095 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000300095 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300095 650_7 $$2Other$$aAdenocarcinoma
000300095 650_7 $$2Other$$aChildhood environment
000300095 650_7 $$2Other$$aFamilial cancer
000300095 650_7 $$2Other$$aMaternal half-sibling
000300095 7001_ $$aZitricky, Frantisek$$b1
000300095 7001_ $$aSundquist, Kristina$$b2
000300095 7001_ $$aSundquist, Jan$$b3
000300095 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b4$$udkfz
000300095 7001_ $$aHemminki, Akseli$$b5
000300095 773__ $$0PERI:(DE-600)2025812-4$$a10.1016/j.lungcan.2025.108500$$gVol. 202, p. 108500 -$$p108500$$tLung cancer$$v202$$x0169-5002$$y2025
000300095 909CO $$ooai:inrepo02.dkfz.de:300095$$pVDB
000300095 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000300095 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000300095 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000300095 9141_ $$y2025
000300095 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
000300095 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLUNG CANCER : 2022$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-11
000300095 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bLUNG CANCER : 2022$$d2024-12-11
000300095 9200_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x0
000300095 9201_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x0
000300095 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000300095 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000300095 980__ $$ajournal
000300095 980__ $$aVDB
000300095 980__ $$aI:(DE-He78)Z999-20160331
000300095 980__ $$aI:(DE-He78)B062-20160331
000300095 980__ $$aI:(DE-He78)HD01-20160331
000300095 980__ $$aUNRESTRICTED